CA2476859A1 - Systemes d'administration a base aqueuse - Google Patents

Systemes d'administration a base aqueuse Download PDF

Info

Publication number
CA2476859A1
CA2476859A1 CA002476859A CA2476859A CA2476859A1 CA 2476859 A1 CA2476859 A1 CA 2476859A1 CA 002476859 A CA002476859 A CA 002476859A CA 2476859 A CA2476859 A CA 2476859A CA 2476859 A1 CA2476859 A1 CA 2476859A1
Authority
CA
Canada
Prior art keywords
delivery system
dihydroxypropyl
acid
hydroxyethyl
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002476859A
Other languages
English (en)
Other versions
CA2476859C (fr
Inventor
Thomas Skold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2476859A1 publication Critical patent/CA2476859A1/fr
Application granted granted Critical
Publication of CA2476859C publication Critical patent/CA2476859C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Abstract

L'invention concerne un système d'administration à base aqueuse d'une substance active, caractérisé par l'amélioration de la restauration de la barrière cutanée dans la stratum corneum, contenant de l'eau, un acide gras, un cholestérol, un céramide et au moins un précurseur de lipide cutané.
CA2476859A 2002-03-13 2003-03-13 Systemes d'administration a base aqueuse Expired - Lifetime CA2476859C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36505902P 2002-03-13 2002-03-13
US60/365,059 2002-03-13
PCT/US2003/007752 WO2003077861A2 (fr) 2002-03-13 2003-03-13 Systemes d'administration a base aqueuse

Publications (2)

Publication Number Publication Date
CA2476859A1 true CA2476859A1 (fr) 2003-09-25
CA2476859C CA2476859C (fr) 2011-09-20

Family

ID=28042008

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2476859A Expired - Lifetime CA2476859C (fr) 2002-03-13 2003-03-13 Systemes d'administration a base aqueuse

Country Status (9)

Country Link
US (3) US20040009213A1 (fr)
EP (1) EP1534213B1 (fr)
JP (1) JP4806519B2 (fr)
KR (1) KR101076335B1 (fr)
AU (1) AU2003233396B2 (fr)
CA (1) CA2476859C (fr)
ES (1) ES2411656T3 (fr)
NZ (1) NZ534377A (fr)
WO (1) WO2003077861A2 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534213B1 (fr) * 2002-03-13 2013-04-24 Sköld, Thomas Systemes d'administration a base aqueuse
FR2855049B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base 6-hydroxy-sphingenine et un activeur de la voie des 6-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
FR2855048B1 (fr) * 2003-05-19 2006-07-21 Oreal Composition comprenant un precurseur de ceramide a base phytosphingosine et un activeur de la voie des 4-hydroxylases, utilisation pour renforcer la fonction barriere de la peau
FR2855047B1 (fr) * 2003-05-19 2007-11-30 Oreal Composition comprenant une base sphingoide, un activateur de la voie des 4-et/ou des 6-hydroxylases et un acide gras, utilisation pour renforcer la fonction barriere de la peau
WO2006133829A2 (fr) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Utilisation de 25-hydroxy-vitamine d3
US20070154403A1 (en) * 2006-01-05 2007-07-05 Thomas Skold Oral, Pulmonary and Transmucosal Delivery Composition
FR2901701B1 (fr) * 2006-05-31 2010-10-29 Galderma Res & Dev Compostions comprenant au moins un derive de l'acide naphtoique et au moins un agent filmogene, leurs procedes de preparation, et leurs utilisations
WO2008029909A1 (fr) * 2006-09-08 2008-03-13 Kaneka Corporation Composition comprenant une coenzyme q10 réduite et de la lysolécithine
JP5196833B2 (ja) * 2007-04-07 2013-05-15 ヤヱガキ醗酵技研株式会社 機能性食品素材とその製造方法
JP2009143897A (ja) * 2007-11-19 2009-07-02 Neochemir Inc ニキビ治療剤
WO2009101412A1 (fr) * 2008-02-13 2009-08-20 Cipla Limited Composition pharmaceutique topique
CN102770162B (zh) 2009-08-21 2016-09-28 靶向递送技术有限公司 囊泡制剂
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
US8613940B2 (en) 2010-09-03 2013-12-24 Eastman Chemical Company Carbonate derivatives as skin care
US9163296B2 (en) 2011-01-25 2015-10-20 Tenaris Coiled Tubes, Llc Coiled tube with varying mechanical properties for superior performance and methods to produce the same by a continuous heat treatment
IT1403689B1 (it) 2011-02-07 2013-10-31 Dalmine Spa Tubi in acciaio ad alta resistenza con eccellente durezza a bassa temperatura e resistenza alla corrosione sotto tensioni da solfuri.
US8329938B2 (en) * 2011-02-21 2012-12-11 Eastman Chemical Company Hydroxyalkanoic acid and hydroxyalkanoice acid oligomer esters of retinol
GB201205642D0 (en) 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
US9803256B2 (en) 2013-03-14 2017-10-31 Tenaris Coiled Tubes, Llc High performance material for coiled tubing applications and the method of producing the same
EP2789700A1 (fr) 2013-04-08 2014-10-15 DALMINE S.p.A. Tuyaux en acier sans soudure trempé et revenu à paroi lourde et procédé de fabrication des tuyaux d'acier
KR102368928B1 (ko) 2013-06-25 2022-03-04 테나리스 커넥션즈 비.브이. 고크롬 내열철강
JP2016523903A (ja) * 2013-07-01 2016-08-12 ネオファーム シーオー．， エルティーディー．Ｎｅｏｐｈａｒｍ Ｃｏ．， Ｌｔｄ． 多層状乳化構造の経皮薬物送達システム
GB201313735D0 (en) * 2013-07-31 2013-09-11 Pro Bono Internat Trading Ltd Vesicles
CN105473162A (zh) * 2013-07-31 2016-04-06 斯昆申技术控股有限责任公司 囊泡
KR101509582B1 (ko) * 2013-10-30 2015-04-14 한국콜마주식회사 감마-리놀레닉산 함유 항염증 및 피부보습 화장용 조성물
EP3069712B1 (fr) * 2013-11-17 2020-09-23 MEDRx Co., Ltd. Agent transdermique en solution colloïdale
CA2932042C (fr) * 2013-12-18 2020-06-02 International Flora Technologies, Ltd. Mimetiques de sebum humain derives de sources botaniques et procedes de fabrication desdits mimetiques
JP6356446B2 (ja) * 2014-03-14 2018-07-11 富士フイルム株式会社 セラミド分散組成物
KR101455684B1 (ko) * 2014-04-29 2014-11-04 주식회사 씨엠에스랩 피부 장벽 개선 및 피부 재생 효과를 갖는 액정유화 화장료 조성물
WO2016118281A1 (fr) 2015-01-20 2016-07-28 TetraDerm Group LLC Véhicule d'administration de médicament topique polyvalent et hydratant tissulaire multifactoriel qui permet la restauration de la barrière muqueuse et cutanée
ES2895910T3 (es) 2015-06-30 2022-02-23 Sequessome Tech Holdings Limited Composiciones multifásicas
US10137073B2 (en) * 2016-01-02 2018-11-27 L'oreal Cosmetic compositions comprising ceramides and cholesterol
KR101750238B1 (ko) * 2016-04-27 2017-06-27 (주)네오팜 항노화용 조성물
KR101752312B1 (ko) * 2016-11-22 2017-06-29 주식회사 씨엠에스랩 사카라이드아이소머레이트, 하이드롤라이즈드루핀프로테인 및 각질세포간지질 모사체를 유효성분으로 담지한 베지클 및 이를 포함하는 피부 외용제 조성물
WO2018123003A1 (fr) * 2016-12-28 2018-07-05 小林製薬株式会社 Composition pour application externe destinée à l'inhibition de la mélanogenèse
KR101910962B1 (ko) * 2017-01-05 2018-10-24 주식회사 마크로케어 세라마이드 액정 조성물 및 이의 제조방법
US10434554B2 (en) 2017-01-17 2019-10-08 Forum Us, Inc. Method of manufacturing a coiled tubing string
EP3632403A4 (fr) * 2017-05-23 2021-03-10 TCI Co., Ltd. Composition liposomale émulsifiée et son procédé de préparation
KR102485259B1 (ko) 2018-03-27 2023-01-06 (주)아모레퍼시픽 모발 상태 개선용 액상 지질 복합 조성물
KR102078667B1 (ko) * 2018-06-18 2020-02-19 주식회사 고운세상코스메틱 7-데하이드로콜레스테롤, 콜레스테롤 및 스테아린산이 히알루론산-세라마이드 엔피 복합체의 내상에 봉입된 나노에멀젼을 함유하는 화장료 조성물 및 그의 제조방법
KR20220137980A (ko) 2020-03-09 2022-10-12 다카사고 고료 고교 가부시키가이샤 세라마이드 증식 촉진제
JP7406057B2 (ja) * 2021-03-03 2023-12-27 東洋ビューティ株式会社 外用微粒子カプセル製剤及び皮膚外用剤

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US4568703A (en) * 1984-07-27 1986-02-04 Bp Chemicals Limited Process for the production of polymers containing isocyanurate and or oxazolidone linkages
JPS62169711A (ja) * 1986-01-22 1987-07-25 Shiseido Co Ltd 皮膚化粧料
US5320906A (en) 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
US5628936A (en) 1987-03-13 1997-05-13 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
CA2067754C (fr) 1990-08-24 2002-06-04 Gregor Cevc Preparation visant l'application d'agents sous forme de mini- gouttelettes
US5665379A (en) 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
US5196190A (en) * 1990-10-03 1993-03-23 Zenith Technology Corporation, Limited Synthetic skin substitutes
US5298246A (en) 1991-01-09 1994-03-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Stable pharmaceutical composition and method for its production
GB9100816D0 (en) * 1991-01-15 1991-02-27 Unilever Plc Cosmetic composition
EP0644764B1 (fr) * 1992-06-19 2000-05-17 The Regents of the University of California Lipides pour l'humidification de l'epiderme et la restauration de la fonction de barriere
JP2832119B2 (ja) * 1992-11-17 1998-12-02 ポーラ化成工業株式会社 化粧料
US5534499A (en) * 1994-05-19 1996-07-09 The University Of British Columbia Lipophilic drug derivatives for use in liposomes
US5631012A (en) * 1994-09-02 1997-05-20 Shanni; David Cosmetic preparations for moisturizing human skin containing specific lipids
US5820873A (en) * 1994-09-30 1998-10-13 The University Of British Columbia Polyethylene glycol modified ceramide lipids and liposome uses thereof
EP0711558A1 (fr) 1994-10-21 1996-05-15 Unilever Plc Des compositions pour application topique sur la peau, les cheveux et les argles
AU690377B2 (en) 1994-11-04 1998-04-23 Polymun Scientific Immunobiologische Forschung Gmbh Application of superoxide dismutase in liposomes
DE4439815C2 (de) 1994-11-08 2001-06-07 Mann & Hummel Filter Filter, insbesondere Flüssigkeitsfilter
FR2728164B1 (fr) * 1994-12-14 1997-03-21 Oreal Composition cosmetique ou dermatologique contenant un melange de ceramides, son utilisation pour hydrater la peau
US20020048596A1 (en) 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
WO1996037192A1 (fr) * 1995-05-26 1996-11-28 Vesifact Ag Compositions pharmaceutiques et cosmetiques contenant des sphingolipides et des glycolipides
US5817856A (en) * 1995-12-11 1998-10-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Radiation-protective phospholipid and method
US6056973A (en) 1996-10-11 2000-05-02 Sequus Pharmaceuticals, Inc. Therapeutic liposome composition and method of preparation
IN184589B (fr) * 1996-10-16 2000-09-09 Alza Corp
WO1998017253A1 (fr) * 1996-10-23 1998-04-30 The Regents Of The University Of California Procede et compositions utilises pour interrompre la fonction de la barriere epitheliale
SE520811C2 (sv) * 1997-01-17 2003-08-26 Ponsus Ab Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
IT1292142B1 (it) 1997-06-12 1999-01-25 Maria Rosa Gasco Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
IT1296914B1 (it) 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
TR200101790T2 (tr) 1998-12-23 2001-10-22 Idea Ag. Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
DE19923246A1 (de) 1999-05-20 2000-12-07 Tyco Electronics Logistics Ag Ferrule für einen Lichtwellenleiter und Verfahren zum Befestigen der Ferrule an dem Lichtwellenleiter
KR19990078610A (ko) 1999-07-03 1999-11-05 김현준 피부보호용조성물
WO2001001962A1 (fr) 1999-07-05 2001-01-11 Idea Ag. Procede d'amelioration du transport a travers des barrieres semi-permeables compatibles
KR100371491B1 (ko) * 1999-07-27 2003-02-07 주식회사 두산 피부 보호용 크림조성물
US6153209A (en) * 1999-09-28 2000-11-28 The Procter & Gamble Company Article having a transferable breathable skin care composition thereon
FR2799650B1 (fr) * 1999-10-14 2001-12-07 Oreal Procede pour limiter la penetration dans la peau et/ou les fibres keratiniques d'un agent cosmetique et/ou pharmaceutique actif
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers
US6824785B1 (en) * 2000-02-09 2004-11-30 C. Neil Kitson Skin treatment composition and methods of use
US6932963B2 (en) * 2000-06-23 2005-08-23 Nicholas V. Perricone Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
US20050129722A1 (en) 2002-03-13 2005-06-16 Collagenex Pharmaceuticals, Inc. Water-based delivery systems
EP1534213B1 (fr) 2002-03-13 2013-04-24 Sköld, Thomas Systemes d'administration a base aqueuse
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery

Also Published As

Publication number Publication date
US20040009213A1 (en) 2004-01-15
WO2003077861A2 (fr) 2003-09-25
AU2003233396A1 (en) 2003-09-29
WO2003077861A3 (fr) 2005-03-24
US20090226491A1 (en) 2009-09-10
NZ534377A (en) 2008-04-30
JP4806519B2 (ja) 2011-11-02
AU2003233396B2 (en) 2007-05-24
EP1534213B1 (fr) 2013-04-24
KR20040091116A (ko) 2004-10-27
EP1534213A2 (fr) 2005-06-01
US8029810B2 (en) 2011-10-04
ES2411656T3 (es) 2013-07-08
JP2005522463A (ja) 2005-07-28
CA2476859C (fr) 2011-09-20
KR101076335B1 (ko) 2011-10-26
EP1534213A4 (fr) 2005-10-26
US20090081139A1 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
CA2476859A1 (fr) Systemes d'administration a base aqueuse
Kogan et al. Microemulsions as transdermal drug delivery vehicles
Foldvari Non-invasive administration of drugs through the skin: challenges in delivery system design
CA1336762C (fr) Methode et composition pour le traitement et la prevention de l'assechement dermique
MX2011003207A (es) Preparaciones farmaceuticas a base de lipidos para la aplicacion oral y topica; sus composiciones, metodos y usos.
US11547665B2 (en) Multiphasic compositions
KR20120129864A (ko) 소포성 제형
KR100446832B1 (ko) 장벽을 통한 활성성분의 비침습성 도포 또는 운반용 제제를 제조하기 위한 액체 소적
US20120141565A1 (en) Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
WO2010140061A2 (fr) Formulations destinées au traitement de la douleur de tissus profonds
Soni et al. Role of liposomal drug-delivery system in cosmetics
WO2006039667A2 (fr) Systemes de distribution a base d'eau
US20110118222A1 (en) Pseudolipid complex mixture and a skin external application composition containing same
US20070224255A1 (en) Liposomal Formulations
Wang et al. The delivery and antinociceptive effects of morphine and its ester prodrugs from lipid emulsions
US20190343748A1 (en) Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration
CA3147460C (fr) Vehicule de substance active insoluble contenant du transfersome
AU2007211879A1 (en) Water-based delivery systems
KR20190085297A (ko) 폴리사카라이드 액정 조성물과 그 제조방법 및 이를 포함하는 화장료 조성물

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20230313